Wells Fargo & Company Immunovant, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Immunovant, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 18,714 shares of IMVT stock, worth $514,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,714
Previous 19,487 3.97%
Holding current value
$514,822
Previous $514,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$27.51 - $27.51 $21,265 - $21,265
-773 Reduced 3.97%
18,714 $514,000
Q2 2024

Aug 13, 2024
BUY
$25.1 - $31.61 $45,807 - $57,688
1,825 Added 10.33%
19,487 $514,000
Q1 2024

May 10, 2024
BUY
$30.27 - $43.79 $36,051 - $52,153
1,191 Added 7.23%
17,662 $570,000
Q4 2023

Feb 09, 2024
SELL
$31.31 - $44.19 $1.58 Million - $2.23 Million
-50,543 Reduced 75.42%
16,471 $693,000
Q3 2023

Nov 13, 2023
SELL
$18.55 - $39.96 $4,785 - $10,309
-258 Reduced 0.38%
67,014 $2.57 Million
Q2 2023

Aug 15, 2023
BUY
$14.2 - $23.75 $56,729 - $94,881
3,995 Added 6.31%
67,272 $1.28 Million
Q1 2023

May 12, 2023
BUY
$15.27 - $19.72 $966,239 - $1.25 Million
63,277 New
63,277 $981,000
Q3 2022

Nov 14, 2022
SELL
$3.93 - $6.37 $1,560 - $2,528
-397 Reduced 76.35%
123 $1,000
Q2 2022

Aug 12, 2022
BUY
$3.38 - $5.65 $1,757 - $2,938
520 New
520 $2,000
Q1 2022

May 16, 2022
SELL
$5.06 - $8.77 $62,860 - $108,949
-12,423 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$7.33 - $9.32 $90,672 - $115,288
12,370 Added 23339.62%
12,423 $105,000
Q3 2021

Nov 15, 2021
SELL
$7.01 - $11.37 $212,802 - $345,159
-30,357 Reduced 99.83%
53 $0
Q2 2021

Aug 16, 2021
SELL
$9.4 - $16.85 $303,497 - $544,035
-32,287 Reduced 51.5%
30,410 $321,000
Q1 2021

May 13, 2021
BUY
$13.08 - $49.6 $295,359 - $1.12 Million
22,581 Added 56.29%
62,697 $1.01 Million
Q4 2020

Feb 09, 2021
SELL
$36.36 - $52.71 $870,131 - $1.26 Million
-23,931 Reduced 37.36%
40,116 $1.85 Million
Q3 2020

Nov 05, 2020
BUY
$22.61 - $38.9 $474,063 - $815,616
20,967 Added 48.67%
64,047 $2.25 Million
Q2 2020

Aug 13, 2020
BUY
$13.87 - $28.44 $597,519 - $1.23 Million
43,080 New
43,080 $1.05 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email